Trials / Completed
CompletedNCT00157898
A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)
A Prospective, Multicenter, Open, Randomized, Comparative Study to Evaluate the Safety and Efficacy of Ertapenem Versus it's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 134 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This was a prospective, randomized, controlled, open, and multi-center trial conducted to compare the clinical efficacy and safety of ertapenem with it's comparator before or following adequate surgical management of complicated intra-abdominal infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0826; ertapenem sodium | |
| DRUG | Comparator: ceftriaxone + metronidazole |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2004-08-01
- Completion
- 2004-09-01
- First posted
- 2005-09-12
- Last updated
- 2017-02-20
Source: ClinicalTrials.gov record NCT00157898. Inclusion in this directory is not an endorsement.